# FDA Inspection 1063022 - Oklahoma Blood Institute East Central - August 03, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/oklahoma-blood-institute-east-central/fd9cd149-e1da-48af-b865-c6307c57ed20/
Source feed: FDA_Inspections

> FDA Inspection 1063022 for Oklahoma Blood Institute East Central on August 03, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1063022
- Company Name: Oklahoma Blood Institute East Central
- Inspection Date: 2018-08-03
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1113288 - 2019-12-11](https://www.globalkeysolutions.net/api/records/fda_inspections/oklahoma-blood-institute-east-central/0fe5028f-a0be-44c6-824c-e5b59e1f8956/)
- [FDA Inspection 970700 - 2016-03-16](https://www.globalkeysolutions.net/api/records/fda_inspections/oklahoma-blood-institute-east-central/2c2a6754-8735-4b0b-a3e6-b3fe8d91074e/)
- [FDA Inspection 868819 - 2014-03-06](https://www.globalkeysolutions.net/api/records/fda_inspections/oklahoma-blood-institute-east-central/ad35e1a2-a0ba-4d3c-9c66-f96870143053/)
- [FDA Inspection 772469 - 2012-03-07](https://www.globalkeysolutions.net/api/records/fda_inspections/oklahoma-blood-institute-east-central/3a6d1f75-72c0-4110-b598-8da050281054/)
- [FDA Inspection 648501 - 2010-02-24](https://www.globalkeysolutions.net/api/records/fda_inspections/oklahoma-blood-institute-east-central/8d744300-869a-441b-9ce3-a91cbff7b19b/)

Company: https://www.globalkeysolutions.net/companies/oklahoma-blood-institute-east-central/64b9341a-19bf-49cf-a835-b72508686f42

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d